BMC Neurology (Jul 2011)

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population

  • Kawamura Nobutoshi,
  • Shimada Hiroyuki,
  • Oeda Tomoko,
  • Yamada Tatsuo,
  • Tsuboi Yoshio,
  • Sasaki Satoshi,
  • Fukushima Wakaba,
  • Tanaka Keiko,
  • Shirasawa Senji,
  • Fujimoto Takahiro,
  • Koyanagi Midori,
  • Miyake Yoshihiro,
  • Kiyohara Chikako,
  • Sakae Nobutaka,
  • Fukuyama Hidenao,
  • Hirota Yoshio,
  • Nagai Masaki

DOI
https://doi.org/10.1186/1471-2377-11-89
Journal volume & issue
Vol. 11, no. 1
p. 89

Abstract

Read online

Abstract Background Parkinson's disease (PD) is characterized by alterations in dopaminergic neurotransmission. Genetic polymorphisms involved in dopaminergic neurotransmission may influence susceptibility to PD. Methods We investigated the relationship of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), dopamine receptor (DR) D2 and DRD4 polymorphisms and PD risk with special attention to the interaction with cigarette smoking among 238 patients with PD and 369 controls in a Japanese population. Results Subjects with the AA genotype of MAOB rs1799836 showed a significantly increased risk of PD (odds ratio (OR) = 1.70, 95% confidence interval (CI) = 1.12 - 2.58) compared with the AG and GG genotypes combined. The AA genotype of COMT rs4680 was marginally associated with an increased risk of PD (OR = 1.86, 95% CI = 0.98 - 3.50) compared with the GG genotype. The DRD2 rs1800497 and DRD4 rs1800955 polymorphisms showed no association with PD. A COMT -smoking interaction was suggested, with the combined GA and AA genotypes of rs4680 and non-smoking conferring significantly higher risk (OR = 3.97, 95% CI = 2.13 - 7.41) than the AA genotype and a history of smoking (P for interaction = 0.061). No interactions of smoking with other polymorphisms were observed. Conclusions The COMT rs4680 and MAOB rs1799836 polymorphisms may increase susceptibility to PD risk among Japanese. Future studies involving larger control and case populations and better pesticide exposure histories will undoubtedly lead to a more thorough understanding of the role of the polymorphisms involved in the dopamine pathway in PD.